<qa>  What is the STUDY OF PRAMIPEXOLE GIVEN?A RANDOMIZED, DOUBLE-BLIND, ACTIVE PRAMIPEXOLE 0.5 MG TID AND PLACEBO CONTROLLED, STUDY OF PRAMIPEXOLE GIVEN 0.5 MG AND 0.75 MG BID OVER 12-WEEK TREATMENT IN EARLY PARKINSONS DISEASE PD PATIENTS: 